ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d26024481e475">Multiple sclerosis (MS) is a complex disease of the central nervous system. As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve. There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe. The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need. The objective was to develop an evidence-based clinical practice guideline for the pharmacological treatment of people with MS to guide healthcare professionals in the decision-making process. </p>

Related collections

Author and article information

Contributors

S. Otero-Romero: (View ORCID Profile)

Journal

Title: European Journal of Neurology

Abbreviated Title: Eur J Neurol

Publisher: Wiley

ISSN: 13515101

Publication date Created: February 2018

Publication date (Print): February 2018

Publication date (Electronic): January 19 2018

Volume: 25

Issue: 2

Pages: 215-237

Affiliations

[1 ]Multiple Sclerosis Centre of Catalonia (Cemcat); Department of Neurology-Neuroimmunology; Vall d'Hebron University Hospital; Barcelona Spain

[2 ]Department of Neurology; Ruhr University, St Josef-Hospital; Bochum Germany

[3 ]Department of Brain Repair and Rehabilitation; Faculty of Brain Sciences; University College London Institute of Neurology; London UK

[4 ]Preventive Medicine and Epidemiology Department; Vall d'Hebron University Hospital; Barcelona Spain

[5 ]Department NEUROFARBA; Section Neurosciences; University of Florence; Florence Italy

[6 ]Multiple Sclerosis International Federation; London UK

[7 ]Department of Neurology; Toulouse University Hospital; Toulouse France

[8 ]Neurological Department; Institute of Experimental Neurology (INSPE); Scientific Institute Hospital San Raffaele; University Vita-Salute San Raffaele; Milan Italy

[9 ]Departments of Neurology and Biomedicine; University Hospital Basel; Basel Switzerland

[10 ]Department of Neurology; Medical University of Graz; Graz Austria

[11 ]Department of Neurology; Medical Faculty, Multiple Sclerosis; Heinrich-Heine-University; Düsseldorf Germany

[12 ]Department of Neurology and Centre of Clinical Neuroscience; First Faculty of Medicine and General University Hospital; Charles University; Prague Czech Republic

[13 ]Department of Neurology; Klinikum Rechts der Isar; Technische Universität München; Munich Germany

[14 ]Munich Cluster for Systems Neurology (SyNergy); Munich Germany

[15 ]University Hospital Basel; Basel Switzerland

[16 ]INSERM UMR U1043 - CNRS U5282; Centre de Physiopathologie de Toulouse Purpan; Université de Toulouse, UPS; Toulouse France

[17 ]ICM-GHU Pitié-Salpêtrière; Sorbonne Universités UPMC Univ Paris 06, UMR_S 1127; Paris France

[18 ]Centre for Outcomes Research and Effectiveness (CORE); Research Department of Clinical, Educational and Health Psychology; University College London; London UK

[19 ]NMR Research Unit; Queen Square Multiple Sclerosis Centre; University College London (UCL) Institute of Neurology; London UK

[20 ]Neuroimmunology Unit; Centre for Molecular Medicine, L8:04; Karolinska University Hospital (Solna); Stockholm Sweden

[21 ]Department of Neurology; Medical University of Lodz; Lodz Poland

[22 ]Clinical Neuroimmunology Unit and MS Clinic; Department of Neurology; Cerrahpasa School of Medicine; Istanbul University; Istanbul Turkey

[23 ]Danish Multiple Sclerosis Centre; Department of Neurology; Copenhagen University Hospital Rigshospitalet; Copenhagen Denmark

[24 ]Biostatistics Unit; University of Genoa; Genoa Italy

[25 ]European Multiple Sclerosis Platform (EMSP); Schaerbeek/Brussels Belgium

[26 ]Department of Neurology; University of Münster; Münster Germany

[27 ]Department of Neurology; Focus Program Translational Neuroscience (FTN) and Immunology (FZI); Rhine-Main Neuroscience Network (rmn2); University Medical Centre of the Johannes Gutenberg University Mainz; Mainz Germany

Article

DOI: 10.1111/ene.13536

PubMed ID: 29352526

SO-VID: 8e30f2e0-0c70-4aa7-bda8-bd8f8bf4113f

License:

http://doi.wiley.com/10.1002/tdm_license_1.1

http://onlinelibrary.wiley.com/termsAndConditions#vor

History

Data availability:

Comments

Comment on this article

scite_

Cited by 127

See all cited by

- Version 1